Local Antiglycan Antibody Responses to Skin Stage and Migratory Schistosomula of Schistosoma Japonicum
Overview
Authors
Affiliations
Schistosomiasis is a tropical disease affecting over 230 million people worldwide. Although effective drug treatment is available, reinfections are common, and development of immunity is slow. Most antibodies raised during schistosome infection are directed against glycans, some of which are thought to be protective. Developing schistosomula are considered most vulnerable to immune attack, and better understanding of local antibody responses raised against glycans expressed by this life stage might reveal possible glycan vaccine candidates for future vaccine research. We used antibody-secreting cell (ASC) probes to characterize local antiglycan antibody responses against migrating Schistosoma japonicum schistosomula in different tissues of rats. Analysis by shotgun Schistosoma glycan microarray resulted in the identification of antiglycan antibody response patterns that reflected the migratory pathway of schistosomula. Antibodies raised by skin lymph node (LN) ASC probes mainly targeted N-glycans with terminal mannose residues, Galβ1-4GlcNAc (LacNAc) and Galβ1-4(Fucα1-3)GlcNAc (LeX). Also, responses to antigenic and schistosome-specific glycosphingolipid (GSL) glycans containing highly fucosylated GalNAcβ1-4(GlcNAcβ1)n stretches that are believed to be present at the parasite's surface constitutively upon transformation were found. Antibody targets recognized by lung LN ASC probes were mainly N-glycans presenting GalNAcβ1-4GlcNAc (LDN) and GlcNAc motifs. Surprisingly, antibodies against highly antigenic multifucosylated motifs of GSL glycans were not observed in lung LN ASC probes, indicating that these antigens are not expressed in lung stage schistosomula or are not appropriately exposed to induce immune responses locally. The local antiglycan responses observed in this study highlight the stage- and tissue-specific expression of antigenic parasite glycans and provide insights into glycan targets possibly involved in resistance to S. japonicum infection.
Glycosphingolipids in human parasites.
Cummings R FEBS Open Bio. 2023; 13(9):1625-1635.
PMID: 37335950 PMC: 10476572. DOI: 10.1002/2211-5463.13662.
Petralia L, van Diepen A, Lokker L, Nguyen D, Sartono E, Khatri V Mol Cell Proteomics. 2022; 21(5):100201.
PMID: 35065273 PMC: 9046957. DOI: 10.1016/j.mcpro.2022.100201.
The Search for a Schistosomiasis Vaccine: Australia's Contribution.
McManus D Vaccines (Basel). 2021; 9(8).
PMID: 34451997 PMC: 8402410. DOI: 10.3390/vaccines9080872.
Glycan Microarray-Assisted Identification of IgG Subclass Targets in Schistosomiasis.
Yang Y, van Diepen A, Brzezicka K, Reichardt N, Hokke C Front Immunol. 2018; 9:2331.
PMID: 30356796 PMC: 6190862. DOI: 10.3389/fimmu.2018.02331.
Antibody responses to Schistosoma mansoni schistosomula antigens.
Egesa M, Lubyayi L, Jones F, van Diepen A, Chalmers I, Tukahebwa E Parasite Immunol. 2018; 40(12):e12591.
PMID: 30239012 PMC: 6492298. DOI: 10.1111/pim.12591.